Malaria Treatment Market is expected to be worth US$ 1.80 billion in 2023, up from US$ 1.72 billion in the fiscal year 2022. From 2023 to 2033, the market is expected to grow at a 5% CAGR, reaching US$ 2.93 billion by the end of that year. Malaria affected over 210 million people worldwide in …
Category Archives: Healthcare Trends
Human Immunodeficiency Virus Type 1 (HIV 1) Market is expected to reach valuation of US$ 62.37 Billion by 2033 | FMI Study
The global Human Immunodeficiency Virus Type 1 (HIV 1) Market is expected to surpass a remarkable valuation of US$ 34.83 billion in 2023, with a compound annual rate of growth (CAGR) of 6% projected from 2023 to 2033. According to the Institute for Health Metrics and Evaluation, the industry’s growth is due to the rising …
Intratumoral Cancer Therapies Market is expected to reach a valuation of US$ 552.36 Billion by 2033 | FMI Study
A recently published study by FMI expects the global Intratumoral Cancer Therapies market to garner a market value of US$ 212.96 Billion in 2023 and is expected to accumulate a market value of US$ 552.36 Billion by registering a CAGR of 10% in the forecast period 2023-2033. Growth of the Intratumoral Cancer Therapies market can be …
Catheter Related Bloodstream Infection (CRBSI) Market is expected to reach a valuation of US$ 80 Billion by 2033 | FMI
The global Catheter Related Bloodstream Infection (CRBSI) Market is expected to generate a market value of US$ 44.67 billion in 2023 and a market value of US$ 80 billion by 2023-2033, at a CAGR of 6%. The increase in the number of people suffering from urinary infections can be attributed to the growth of the …
Embryo Incubator Market to expand at a 5% value CAGR by 2032
The global embryo incubator market is anticipated to be valued at US$ 77.8 million in 2022, rising to US$ 132.9 million by 2032, with a CAGR of 5% from 2022 to 2032. The market’s expansion can be ascribed to an increase in the use of in-vitro fertilisation methods among patients to aid in reproduction. Embryo …
Continue reading “Embryo Incubator Market to expand at a 5% value CAGR by 2032”
Outsourced Testing Services Market is expected to reach US$ 76.3 Billion by 2032
The global outsourced testing services market is expected to be worth $36.4 billion in 2022 and to grow at a 7.7% CAGR to $76.3 billion by 2032. According to a new Future Market Insights analysis, pharma/biopharmaceuticals testing will command a 40.8% share of the global market in 2021. The increase in the number of infectious …
Continue reading “Outsourced Testing Services Market is expected to reach US$ 76.3 Billion by 2032”
Sphingolipids Market is expected to reach US$ 991.8 Million by 2032
The global sphingolipids market was valued at approximately US$ 564.0 Million in 2021, with the global market expected to grow at a 5.1% CAGR to an anticipated valuation of approximately US$ 991.8 Million by the end of 2032. As of 2021, conventional lipid-based drug delivery systems (LBDDS) account for 61.9% of the worldwide sphingolipids market. …
Continue reading “Sphingolipids Market is expected to reach US$ 991.8 Million by 2032”
Point-Of-Care Breathalyser Market to expand at a 5.5% value CAGR by 2032
The global Point-Of-Care Breathalyser Market is expected to be worth US$ 385.7 million in 2022, with a CAGR of 5.5% to reach US$ 658.9 million by 2032. Alcohol usage is being blamed for the increase in growth. The point-of-care breathalyser market grew at a CAGR of 5.2% between 2016 and 2021. Breathalyzer is a non-invasive …
Continue reading “Point-Of-Care Breathalyser Market to expand at a 5.5% value CAGR by 2032”
Drug Formulation Market is expected to reach US$ 2.87 Trillion by 2032
Over the projected period of 2022 to 2032, global demand for drug formulation is expected to grow at a 5.6% CAGR. The pharmaceutical formulations market is expected to be worth $1.58 trillion by 2022. Oral formulations are expected to rise exponentially at a CAGR of 6.0% during the forecast period, according to the study. As …
Continue reading “Drug Formulation Market is expected to reach US$ 2.87 Trillion by 2032”
Inhalation and Nasal Spray Generic Drugs Market is predicted to advance at a CAGR of 8.96% through 2032
During the forecast period, the global Inhalation and Nasal Spray Generic Drugs Market is expected to grow at a moderate rate of 8.96%. The market for inhalation and nasal spray generic pharmaceuticals is currently valued at US$ 20.78 billion in 2023. The market for inhalation and nasal spray generic pharmaceuticals is expected to reach a …